Laurent Humeau - 09 Jun 2021 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Chief Scientific Officer
Signature
/s/ Laurent Humeau
Issuer symbol
INO
Transactions as of
09 Jun 2021
Net transactions value
-$93,584
Form type
4
Filing time
11 Jun 2021, 16:25:53 UTC
Next filing
11 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Sale $93,584 -10,318 -12% $9.07* 78,904 09 Jun 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 These transactions were executed in multiple trades at prices ranging from $8.91 to $9.22, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.